Navigation Links
Virginian-Pilot Story Misleads Readers on USDA Inspection Report for PLRS
Date:10/8/2010

CORAPEAKE, N.C., Oct. 8 /PRNewswire/ -- Contrary to a report in today's Virginian-Pilot, a comprehensive inspection by the U.S. Department of Agriculture (USDA) of NC-based Professional Laboratory and Research Services (PLRS) has found no evidence of animal neglect or abuse. The USDA finding follows People for the Ethical Treatment of Animals' (PETA) September release of a contrived video that inaccurately depicts the conditions at PLRS, in a malicious attempt to force the small business to close its doors.  

Two USDA veterinarians visited PLRS on September 13 and 14, 2010 and conducted a thorough medical review of every animal at the facility.  Their inspection revealed no evidence of abuse or neglect.  In addition, USDA performed a routine inspection of the facility on July 7, 2010 – during the time PETA's operative was working there – and found no evidence that would corroborate the group's baseless claims.  

"PLRS was the target of a premeditated smear campaign by PETA, a group that opposes all forms of biomedical research," stated veterinary parasitologist and PLRS Vice President Dr. Larry Cruthers, Ph.D.  "PETA's contrived video was engineered to mislead the public about PLRS and the company's strong commitment to animal welfare and regulatory compliance.  The USDA's inspection report shows there is no proof to PETA's unfounded accusations."

In the company's 24-year history, it has never been the subject of an enforcement action by USDA.  The USDA has rigorously inspected the PLRS facility on an annual basis, using trained, experienced USDA veterinarians.  Since the company's founding, multiple veterinarians have been called upon to inspect and treat PLRS' animals.  Sponsors who funded the tests also made regular visits, including veterinarians employed by these same sponsors, without any complaints of animal neglect such as those alleged by PETA.  

The most recent USDA inspection report noted only minor "correctable findings" that are not uncommon to animal research facilities and, more importantly, do not reflect any type of animal abuse whatsoever.  For context, nearly 50 percent of currently registered animal research facilities in North Carolina received correctable findings in their most recent USDA inspection reports, and each of these facilities, including PLRS, remains open today.

PLRS takes seriously its responsibility of caring for the welfare of all animals at its facility.   As examples:

  • The company has strict compliance policies and has well-established protocols for monitoring employee behavior and reporting any allegation of animal abuse of any kind.
  • Comprehensive training programs are required of all PLRS animal technicians.
  • Research protocols followed at PLRS reflect procedures consistent with those used at other facilities, which are routinely accepted and approved by multiple federal grant-making authorities. PLRS consultant Dr. Daniel Sonenshine stated: "PLRS tests products produced by pharmaceutical and pet products companies that protect pets and other animals from attack by ticks that transmit the agents of such human diseases as Lyme disease, Rocky Mountain Spotted Fever, and other challenging illnesses.  These tests are required by regulatory agencies in order for these companies to register their products and bring them to market."  
  • PLRS has an Animal Care and Use Committee (IACUC) to approve and review all use of animals for research, as required by the Animal Welfare Act. The IACUC includes a veterinarian in its membership, as well as one or more members of the local community with no affiliation to the company.  

The vast majority of the nation's scientific community recognizes the important role animals play in the advancement of disease research.  "PETA's reckless anti-cure agenda puts human and animal health at serious risk," Dr. Larry Cruthers, Ph.D., continued. "PLRS will not allow PETA to misrepresent the company's work to test the safety and effectiveness of products being developed by the pharmaceutical and pet product industries to promote animal and human health."


'/>"/>
SOURCE Professional Laboratory and Research Services
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. WellSpring Pharmaceutical, American Gastroenterological Association, and Steven Bramson of Humanscale Partner With MediaPlanet to Publish One of the Largest Digestive Wellness Campaigns in U.S. History to Overcome Upset Stomach, Nausea, IBS, and Deb
2. Shield Healthcare Announces 10th Annual Caregiver Story Contest
3. An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists
4. Texas Childrens Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device
5. Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
6. For the First Time, Blood Donors May Answer Their Health History Questions Online From the Privacy of Their Home or Office
7. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
8. Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
9. Study Finds Family History, Higher Incidence of Sunburns Associated With Rosacea
10. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
11. Almacs Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016   Lexicon Pharmaceuticals, ... results today from a Phase 2 clinical study of ... Lexicon in collaboration with JDRF, the leading global organization ... of this Phase 2 clinical trial, which randomized a ... of a once-daily 400 mg dose of sotagliflozin compared ...
(Date:12/5/2016)... , December 5, 2016 According to ... Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), ... by MarketsandMarkets, the market is projected to reach USD 779.8 Million ... CAGR of 13.5% during the forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... PORTLAND, Oregon and PUNE, India ... a new report by Allied Market Research, titled, "Global Cancer ... the global revenue of cancer biomarkers market is projected to ... at a CAGR of 13.3% from 2016 to 2022. Omic ... share in 2015 and is expected to maintain its dominance ...
Breaking Medicine Technology:
(Date:12/6/2016)... , ... December 06, 2016 ... ... on Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. ... eye-catching label design. Featuring one of the world’s most powerful antioxidants, molecular ...
(Date:12/6/2016)... ... December 06, 2016 , ... TopConsumerReviews.com recently gave a ... Scooters . , Mobility Scooters give freedom to people who need help getting around. ... may be facing a long period of rehabilitation after an illness or accident. There ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is a ... lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO of ... create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... GA (PRWEB) , ... December ... ... technology and security executive networking and relationship-marketing firm, announced today that nominations ... the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include the ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education ... Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on ... “We are honored to have Amy E. Herman present at this year’s conference, ...
Breaking Medicine News(10 mins):